Completed NA INTERVENTIONAL 1-arm NCT06097988

Study on Knee Osteoarthritis (PILHAC)

A Prospective, Multicenter Clinical Investigation Evaluating the Safety of ABIO3419 in Treating Knee Osteoarthritis: Pilot Study

Sponsor: Symatese

Conditions Knee Osteoarthritis

Interventions ABIO3419

Updated 6 times since 2023 Last updated: Nov 14, 2024 Started: Feb 2, 2024 Primary completion: Jun 19, 2024 Completion: Sep 16, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06097988, this NA trial focuses on Knee Osteoarthritis and remains completed. Sponsored by Symatese, it has been updated 6 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2023 — Mar 2024 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Nov 2023 — Dec 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Symatese

Data source: Symatese

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riga, Latvia